These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 17716621
21. Perturbation of the titin/MURF1 signaling complex is associated with hypertrophic cardiomyopathy in a fish model and in human patients. Higashikuse Y, Mittal N, Arimura T, Yoon SH, Oda M, Enomoto H, Kaneda R, Hattori F, Suzuki T, Kawakami A, Gasch A, Furukawa T, Labeit S, Fukuda K, Kimura A, Makino S. Dis Model Mech; 2019 Nov 15; 12(11):. PubMed ID: 31628103 [Abstract] [Full Text] [Related]
23. The crystal structure of the human titin:obscurin complex reveals a conserved yet specific muscle M-band zipper module. Pernigo S, Fukuzawa A, Pandini A, Holt M, Kleinjung J, Gautel M, Steiner RA. J Mol Biol; 2015 Feb 27; 427(4):718-736. PubMed ID: 25490259 [Abstract] [Full Text] [Related]
24. Developmental expression and differential cellular localization of obscurin and obscurin-associated kinase in cardiac muscle cells. Borisov AB, Raeker MO, Russell MW. J Cell Biochem; 2008 Apr 01; 103(5):1621-35. PubMed ID: 18041765 [Abstract] [Full Text] [Related]
25. Binding of Myomesin to Obscurin-Like-1 at the Muscle M-Band Provides a Strategy for Isoform-Specific Mechanical Protection. Pernigo S, Fukuzawa A, Beedle AEM, Holt M, Round A, Pandini A, Garcia-Manyes S, Gautel M, Steiner RA. Structure; 2017 Jan 03; 25(1):107-120. PubMed ID: 27989621 [Abstract] [Full Text] [Related]
26. Obscurin variants and inherited cardiomyopathies. Marston S. Biophys Rev; 2017 Jun 03; 9(3):239-243. PubMed ID: 28510120 [Abstract] [Full Text] [Related]
27. Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway. Ackermann MA, King B, Lieberman NAP, Bobbili PJ, Rudloff M, Berndsen CE, Wright NT, Hecker PA, Kontrogianni-Konstantopoulos A. J Mol Cell Cardiol; 2017 Oct 03; 111():27-39. PubMed ID: 28826662 [Abstract] [Full Text] [Related]
28. Obscurin regulates the organization of myosin into A bands. Kontrogianni-Konstantopoulos A, Catino DH, Strong JC, Randall WR, Bloch RJ. Am J Physiol Cell Physiol; 2004 Jul 03; 287(1):C209-17. PubMed ID: 15013951 [Abstract] [Full Text] [Related]
29. Titin mutations as the molecular basis for dilated cardiomyopathy. Itoh-Satoh M, Hayashi T, Nishi H, Koga Y, Arimura T, Koyanagi T, Takahashi M, Hohda S, Ueda K, Nouchi T, Hiroe M, Marumo F, Imaizumi T, Yasunami M, Kimura A. Biochem Biophys Res Commun; 2002 Feb 22; 291(2):385-93. PubMed ID: 11846417 [Abstract] [Full Text] [Related]
30. Novel OBSCN variants associated with a risk to exercise-intolerance and rhabdomyolysis. Zemorshidi F, Töpf A, Claeys KG, McFarlane A, Patton A, Nafissi S, Straub V. Neuromuscul Disord; 2024 Jan 22; 34():83-88. PubMed ID: 38159459 [Abstract] [Full Text] [Related]
31. Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin. Bos JM, Poley RN, Ny M, Tester DJ, Xu X, Vatta M, Towbin JA, Gersh BJ, Ommen SR, Ackerman MJ. Mol Genet Metab; 2006 May 22; 88(1):78-85. PubMed ID: 16352453 [Abstract] [Full Text] [Related]
32. A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy. Freiburg A, Gautel M. Eur J Biochem; 1996 Jan 15; 235(1-2):317-23. PubMed ID: 8631348 [Abstract] [Full Text] [Related]
33. Structural analysis of four and half LIM protein-2 in dilated cardiomyopathy. Arimura T, Hayashi T, Matsumoto Y, Shibata H, Hiroi S, Nakamura T, Inagaki N, Hinohara K, Takahashi M, Manatsu SI, Sasaoka T, Izumi T, Bonne G, Schwartz K, Kimura A. Biochem Biophys Res Commun; 2007 May 25; 357(1):162-7. PubMed ID: 17416352 [Abstract] [Full Text] [Related]
34. Obscurin is required for the lateral alignment of striated myofibrils in zebrafish. Raeker MO, Su F, Geisler SB, Borisov AB, Kontrogianni-Konstantopoulos A, Lyons SE, Russell MW. Dev Dyn; 2006 Aug 25; 235(8):2018-29. PubMed ID: 16779859 [Abstract] [Full Text] [Related]
35. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. Hayashi T, Arimura T, Itoh-Satoh M, Ueda K, Hohda S, Inagaki N, Takahashi M, Hori H, Yasunami M, Nishi H, Koga Y, Nakamura H, Matsuzaki M, Choi BY, Bae SW, You CW, Han KH, Park JE, Knöll R, Hoshijima M, Chien KR, Kimura A. J Am Coll Cardiol; 2004 Dec 07; 44(11):2192-201. PubMed ID: 15582318 [Abstract] [Full Text] [Related]
39. Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line. Cunha SR, Mohler PJ. J Biol Chem; 2008 Nov 14; 283(46):31968-80. PubMed ID: 18782775 [Abstract] [Full Text] [Related]
40. Orthologous relationship of obscurin and Unc-89: phylogeny of a novel family of tandem myosin light chain kinases. Sutter SB, Raeker MO, Borisov AB, Russell MW. Dev Genes Evol; 2004 Jul 14; 214(7):352-9. PubMed ID: 15185077 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]